Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Risk adjusted net present value: What is the current valuation of Cerevel Therapeutics's Darigabat?
Darigabat is a small molecule commercialized by Cerevel Therapeutics, with a leading Phase II program in Seizures. According to Globaldata,...
Darigabat by Cerevel Therapeutics for Panic Disorders: Likelihood of Approval
Darigabat is under clinical development by Cerevel Therapeutics and currently in Phase II for Panic Disorders. According to GlobalData, Phase...
Risk adjusted net present value: What is the current valuation of Cerevel Therapeutics's Darigabat?
Darigabat is a small molecule commercialized by Cerevel Therapeutics, with a leading Phase II program in Seizures. According to Globaldata,...